Suppr超能文献

鼻腔鼻窦腺样囊性癌:临床结果和预测因素。

Sinonasal adenoid cystic carcinomas: clinical outcomes and predictive factors.

机构信息

Department of Otolaryngology-Head and Neck Surgery, La Timone Universitary Hospital Center, Marseille, France.

出版信息

Int J Oral Maxillofac Surg. 2013 Feb;42(2):153-7. doi: 10.1016/j.ijom.2012.11.007. Epub 2012 Dec 6.

Abstract

This is a retrospective study of 11 patients treated for sinonasal adenoid cystic carcinomas (ACCs) between 1989 and 2008. The authors statistically analysed the epidemiological, clinical, histological and therapeutic aspects of this series of patients with sinonasal ACCs and their impact in terms of overall and disease-free survival established using the Kaplan-Meier method. A search for prognostic factors was made using a log-rank test. There were 5 women (45.4%) and 6 men (54.6%). Average age at diagnosis was 52.2 years (24-75 years). Mean follow-up of patients was 63 months (11-142 months). Tumours were classified as T1 in 9%, T2 in 45.4% and T4 in 45.4% of cases. Disease-free survival rates at 1, 5 and 10 years were 83%, 41% and 18%, respectively, and overall survival rates were 100%, 64% and 35%, respectively. Surgery followed or not by radiotherapy resulted in better survival than other treatment, regardless of tumour stage. Better disease-free survival with postoperative radiotherapy was not found. These tumours should be treated by surgical resection with clear margins followed by adjuvant radiotherapy.

摘要

这是一项回顾性研究,共纳入了 1989 年至 2008 年间 11 例接受治疗的鼻腔鼻窦腺样囊性癌(ACC)患者。作者对该组鼻腔鼻窦 ACC 患者的流行病学、临床、组织学和治疗方面进行了统计学分析,并采用 Kaplan-Meier 方法评估了总生存和无病生存情况。使用对数秩检验寻找预后因素。该研究中,女性 5 例(45.4%),男性 6 例(54.6%)。诊断时的平均年龄为 52.2 岁(24-75 岁)。患者的中位随访时间为 63 个月(11-142 个月)。肿瘤分期中 T1 占 9%,T2 占 45.4%,T4 占 45.4%。1、5、10 年无病生存率分别为 83%、41%和 18%,总生存率分别为 100%、64%和 35%。手术联合或不联合放疗的生存情况优于其他治疗方式,与肿瘤分期无关。术后放疗并未改善无病生存情况。这些肿瘤应通过手术切除并获得清晰的切缘,术后辅助放疗。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验